Axogen, Inc.
AXGN· Nasdaq
AXGNAxogen, Inc.
Filed Feb 25, 2022 · 10-K · 56 days after period end · 0000805928-22-000026
derived · Computed from the longer spans the company filed.
| Metric | Q4 2021dderived from reported figures | Q4 2020 | Q4 2019 | Q4 2018 |
|---|---|---|---|---|
| Revenue | $31.54M | $32.50M | $28.16M | $23.43M |
| Net Income | -$5.29M | -$6.01M | -$7.04M | -$5.22M |
| EPS Diluted | — | -$0.15 | -$0.18 | -$0.13 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Axogen, Inc. · CIK 805928 · Engraved from SEC EDGAR
ended Dec 31, 2021 · filed Feb 25, 2022 · 56 d after period end
